Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB25FZMZ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,249
Award facts
- Contract value 100% obligated
- $6,249.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a $6,249.24 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 2, 2025, for Mirena 52 mg contraceptive systems. This delivery order represents one of numerous awards issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026. The contract was awarded without a set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical procurement market. Performance is scheduled for completion by September 23, 2025, with fulfillment occurring at the contractor's Park Ridge, Illinois facility.
This delivery order exemplifies DMS Pharmaceutical Group's critical role as a pharmaceutical supplier to the Defense Logistics Agency, supporting medical supply needs across Department of Defense healthcare facilities worldwide. The DLA's SPE2DB indefinite delivery vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including contraceptive devices, prescription medications, biologics, and medical consumables on an as-needed basis. DMS Pharmaceutical Group has demonstrated consistent success in securing federal pharmaceutical contracts since its SAM.gov registration in 2001, leveraging its woman-owned small business status and established relationships with the DLA to maintain a robust position in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FZMZ4?
SPE2DB25FZMZ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FZMZ4 worth?
The government has obligated $6,249 on SPE2DB25FZMZ4.
Is contract SPE2DB25FZMZ4 an order under another contract?
Yes. SPE2DB25FZMZ4 is a delivery order under SPE2DB24D9210, an indefinite delivery contract.
Was contract SPE2DB25FZMZ4 competed?
The extent of competition for SPE2DB25FZMZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award